Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sana Biotechnology Inc (NQ: SANA )

3.270 +0.160 (+5.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,163,013
Open 3.130
Bid (Size) 3.100 (1)
Ask (Size) 3.280 (16)
Prev. Close 3.110
Today's Range 3.100 - 3.290
52wk Range 2.990 - 9.600
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Sana Biotechnology Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
From Sana Biotechnology, Inc
Via Globe NewsWire
Sana Biotechnology Announces the Acceptance of Four Abstracts for Presentation at the 2023 American Association for Cancer Research Annual Meeting
Late-breaking poster presentation to highlight preclinical data demonstrating that the increased potency of CD8-targeted fusosomes enhances CAR gene delivery to resting primary T cells 
From Sana Biotechnology, Inc
Via Globe NewsWire

Performance

YTD
-12.33%
-12.33%
1 Month
-8.91%
-8.91%
3 Month
-17.22%
-17.22%
6 Month
-45.50%
-45.50%
1 Year
-60.41%
-60.41%

More News

Read More
Sana Biotechnology to Present at the Cowen 43rd Annual Health Care Conference
From Sana Biotechnology, Inc
Via Globe NewsWire
Morgan Stanley Maintains Overweight Rating for Sana Biotechnology: Here's What You Need To Know
Via Benzinga
Sana Biotechnology Outlines Pipeline Prioritization, Reduces Workforce
Via Benzinga
Sana Biotechnology to Present at the Guggenheim Healthcare Talks 5th Annual Oncology Conference
From Sana Biotechnology, Inc
Via Globe NewsWire
Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-targeted Allogeneic CAR T Therapy for Patients with B-Cell Malignancies
From Sana Biotechnology, Inc
Via Globe NewsWire
Sana Biotechnology to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Sana Biotechnology, Inc
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Sana Biotechnology Highlights Hypoimmune Allogeneic CAR T Cell Programs and in vivo Technology Platform with Six Presentations at 2022 ASH Annual Meeting
From Sana Biotechnology, Inc
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Sana Biotechnology Confirms Key Program Timelines and Announces Portfolio Prioritization
From Sana Biotechnology, Inc
Via Globe NewsWire
Vodafone, Getty Images Holdings, Haynes International And Some Other Big Stocks Moving Lower On Tuesday
Via Benzinga
Sana Biotechnology Tops BioSpace’s 2023 Best Places to Work Ranking in Small Employer Category
From Sana Biotechnology, Inc
Via Globe NewsWire
Sana Biotechnology Announces Several Preclinical Data Presentations at the 64th American Society of Hematology Annual Meeting
From Sana Biotechnology, Inc
Via Globe NewsWire
Sana Biotechnology Reports Third Quarter 2022 Financial Results and Business Updates
From Sana Biotechnology, Inc
Via Globe NewsWire
7 Unknown Biotech Stocks That Could Rocket in 2023
Via InvestorPlace
7 Stocks Due for a Stunning Short Squeeze
Via InvestorPlace
DocuSign CEO Shuffle: Why One Analyst Remains On The Sidelines For Now
Via Benzinga
21 Stocks Moving in Wednesday's Pre-Market Session
Via Benzinga
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
89 Biggest Movers From Friday
Via Benzinga
92 Biggest Movers From Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.